OpGen, Inc. (OPGN) - שווי החברה ברכישה מלאה

OpGen, Inc. (OPGN) holds a leading position in rapid pathogen diagnostics, promptly identifying bacterial resistance to therapy to save lives. This price chart reflects an Enterprise Value of . This price action is driven by the implementation of digital profiling systems in clinics and the anticipation of global contracts. Business stability is ensured by the high demand for Acuitas tests in hospitals, where demand remains insensitive to cost.

Enterprise value combines market capitalization and net debt, determining the actual cost of a full business buyout accounting for all liabilities and cash holdings. Analyzing the adjusted enterprise value for OpGen, Inc. (OPGN) is critical, as declining demand for diagnostics and a high proportion of fixed costs leave the company vulnerable to debt burdens amid low efficiency levels.